This is a combination contains Domperidone and Rabeprazole. Domperidone works on the upper digestive tract to increase the peristaltic movement, allowing the food to move more easily through the stomach. Rabeprazole is categorised as proton pump inhibitor (PPI) that stops gastric acid secretion in the stomach that provide relief from acid-related indigestion and heartburn.

Gastroesophageal reflux disease (GERD)
Zollinger-Ellison Syndrome
Peptic ulcer
Erosive Esophagitis (EE)
Bacterial Infection Due to Helicobacter Pylori

Rabeprazole decreases gastric acid production. Rabeprazole may also be used with other antibiotics in H. pylori infection along that are associated with gastric ulcers. Rabeprazole inhibits proton pump irreversibly and is very selective and hence suppresses gastric acid secretion by particularly inhibition of the H+, K+ -ATPase, which is found at the secretory surface of parietal cells.

Domperidone is a specific blocker of dopamine receptors. It increases peristaltic moment, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms. Domperidone improvess gastric emptying and decreases small bowel transit time by increasing esophageal and gastric peristalsis and by lowering esophageal sphincter pressure. Domperidone works by blocking D2 and D3 dopamine receptors present in CTZ (chemoreceptor trigger zone) and shows antiemetic property. It is more selective for the receptors which are found in the chemoreceptor trigger zone, located just outside the blood brain barrier, which - among others - regulates nausea and vomiting.

Rabeprazole is absorbed from GIT with a bioavailability of about 52%. Rabeprazole shows 96.3% of plasma protein binding and is extensively metabolised in liver. Approximately 90% of the drug was eliminated in the urine and the half-life is 1-2 hours in plasma.

Domperidone is effectively absorbed from GIT and the bioavailability is only 20% due to high first pass metabolism. 91%-93% of the dose administered is bound to plasma protein with a half-life of 7 hours. The metabolites are mainly excreted in urine and feces.

Diarrhea
Stomach pain
Flatulence
Dryness in mouth
Dizziness
Headache

Carefully use in patients with renal and hepatic impairment
Hypersensitivity can occur in patient with phaeochromocytoma
Systemic lupus erythematosus

#
Each Hard Gelatin Capsule Contains:
Rabeprazole 20 mg
Domperidone 30 mg